832-497-2220 info@mybiogate.com
Hamburg
Nov 10, 2019

Grand Elysée Hamburg
Rothenbaumchaussee 10 | 20148 Hamburg, Germany

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)




1-ON-1 MEETING
Meet the right people and achieve your goals through one-to-one meetings.
Our Online partnering platform is now open. Registered attendees will receive sign-in information via email.

About China Focus ®

China Focus® brings together investors, pharma leaders, and biotech & Medtech innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations. The pharma market in China grew to ~Rmb1,558bn (US$226bn) in 2018, at a CAGR of 10% in 2013-18, becoming the 2nd largest pharma market in the world. As the youngest member of ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), China joined with the least experience but holding the promise to bring domestic clinical trials to world standard and open its market. There will be new revenues for innovative therapeutics and more business development opportunities for global players. The current U.S.-China relationship and CFIUS regulations in the U.S. derived interest from some Chinese investors to the European market.

Following the successful China Focus@Europe Vienna in March 2019,we have received increasing interest from Chinese companies to expand business development activities in European countries. In order to better connect Chinese companies and European markets, China Focus comes to Europe again this November, featuring keynote speech, panel discussion, Chinese companies showcase, 1-on-1 meeting, and company presentation (Pitch & Match).

Who should attend

 

  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers

Main topics

 

  • NMPA (previously CFDA) regulatory reforms and new opportunities for biotech & pharma
  • Opportunities and barriers for new Chinese players entering the market
  • New IPO opportunities and the impact on the valuation of biotech companies: HKEX and STAR Market
  • European biotech space: how is it unique?
  • Current and future hot spots in modality and therapeutic area – how can China and Europe join forces?

What you can get

 

  • Learn about Chinese life science and healthcare industry
  • Hear the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start
ATTENDEE DEMOGRAPHICS
at Previous China Focus Events
AGENDA

 

Room Theme Time
Speicherstadt II Plenary Session 9:00 – 17:00
Speicherstadt I 1-on-1 Partnering Meetings 10:00 – 17:00
Amerika Haus MyBioGate Global Healthcare Innovation Competition 10:00 – 12:00
Galerie Grand Foyer Reception 17:00 – 19:00

 

 

Time Plenary session (Room Speicherstadt II)
9:00 AM – 9:40 AM Opening Remarks
Keynote: China’s Role in Healthcare investment and partnership in Europe
Stephen Sunderland – Partner, L.E.K. Consulting
9:40 AM – 10:40 AM Panel 1: Regulatory reforms in China and the impact on cross-border collaborations
Moderator: Yan Song – Founder and CEO, Link Health Group
Panelist:
Xiaoli Li – Global Product Manager, Merck Group
Yongan (Andy) Li – President and CEO, BioSense Global LLC
Binhui (Ben) Ni – Managing Partner, IN Capital
Weibin (William) Wang – Executive VP, Yiling Pharmaceutical
10:40 AM – 11:00 AM Coffee Break
11:00 AM – 12:00 PM Panel 2: European’s healthcare innovations meet the China market
Moderator: Chenchao Liu – Founder & CEO of Silreal; Co-founder & Chairman of Sino-European Digital Health Club
Panelists:
James Huang – Managing Partner, KPCB China 
Jinchen Yu – Senior Vice President of Research, BIO-THERA
Xiaofei Zhang – VP European Operations, Link Health Group
Zhongyuan (John) Zhu – Partner, 6 Dimensions Capital
12:00 PM – 1:30 PM Lunch break (Galerie Grand Foyer)
1:30 PM – 2:30 PM

Panel 3: European pharmaceutical pricing regulation – opportunities and barriers for new Chinese players entering the market
Moderator: Sebastian Gensior – Founder of Sino European Pharma Forum; Managing Director at Global Health Access Solutions
Panelists:
Michal Czarnuch – Partner, Domanski Zakrzewski Palinka
Marcus Guardian – Chief Operating Officer, EUnetHTA
Peter Hertzman – Founder and Principal Consultant, Health Access Agency

2:30 PM – 2:50 PM Company Presentation (part 1)
2:50 PM – 3:15 PM Coffee Break
3:15 PM – 3:40 PM Featured talk: Develop new drugs in China under a licensing agreement
Yan Song – Founder and CEO, Link Health Group
3:40 PM – 4:00 PM Company Presentation (part 2)
4:00 PM – 5:00 PM

Panel 4: Recipe for a successful cross-border partnership
Moderator: Echo Hindle-Yang – CEO, MSQ Ventures
Panelists:
Jürgen Gamer – VP Business Development, Apogenix GmbH
Brian Yang – Director of Business Development and Finance, Terns Pharmaceuticals
Weiping Yang – CEO, ApolloBio Corporation
Sally Zheng – Founder and Managing Partner at Global Alpha Ventures; Managing Partner at Fosun NExT Investment Group

5:15 PM – 7:00 PM Reception (Galerie Grand Foyer)

 

FEATURED SPEAKERS

(arranged by surnames in the alphabetical order)

Michal Czarnuch

Partner

Domanski Zakrzewski Palinka

Jürgen Gamer

VP Business Development

Apogenix GmbH

Sebastian Gensior

Founder, Sino-European Pharma Forum (SEPF)

Managing Director, Global Health Access Solutions

Marcus Guardian

Chief Operating Officer

European Network of Health Technology Assessment (EUnetHTA)

Peter Hertzman

Founder and Principal Consultant

Health Access Agency

Echo Hindle-Yang

CEO

MSQ Ventures

James Huang

Managing Partner

KPCB China

Andy Li

CEO and President

BioSense Global LLC

Xiaoli Li

Global Product Manager

Merck Group

Chenchao Liu

Co-founder & Chairman, Sino-European Digital Health Club

Founder & CEO, Silreal

Binhui (Ben) Ni

Managing Partner

IN Capital

Yan Song

Founder and CEO

Link Health Group

Stephen Sunderland

Partner

L.E.K. Consulting

Brian Yang

Director of Business Development and Finance

Terns Pharmaceuticals

Weiping Yang

CEO

ApolloBio Corporation

Jinchen Yu

Senior Vice President, Research

BIO-THERA

Xiaofei Zhang

VP European Operations

Link Health Group 

Sally Zheng

Founder & Managing Partner, Global Alpha Ventures

Managing Partner, Fosun NExT Investment Group

Zhongyuan (John) Zhu

Partner

6 Dimensions Capital

Attendees

Chinese Companies and Investors

%

Executive Level Attendees

One-to-one meetings

apply to present
Get an audience list from China’s top-tier pharmaceutical companies and investors in advance. Pitch your company and secure one-on-one meetings with the right audience
GENERAL REGISTRATION
Learn about opportunities from the rising healthcare market, innovation and investment trend in China from industry leaders
INVESTOR REGISTRATION
Qualified investors can request a complimentary registration
MEDIA  REGISTRATION
Member of the press can request for a complimentary regisitration

Download Sample Attendee List from past China Focus events

Download Program from past China Focus events
Sponsor & Partner

Boost company exposure and brand awareness through digital and onsite visibility

Receive consultation service and priority in the partnering process

Position your company as a leader within the life science industry through sponsorship

Customizable sponsorship packages

SPONSORS AND PARTNERS

REGISTRATION

CONTACT US

4 + 12 =

Registration, Sponsorship and Collaboration (China)
Youwen (Allen) Dai youwen.dai@mybiogate.com

Registration, Sponsorship and Collaboration (U.S. & Europe) Xinxin Li Xinxin.li@mybiogate.com

Speaker, Group Delegation and Presenting Companies
Han Yan han.yan@mybiogate.com

General Inquiries info@mybiogate.com
                           +1-832-497-2220

FORUM VENUE
Address:

Grand Elysée Hamburg
Rothenbaumchaussee 10
20148 Hamburg, Germany

Phone: +49 40 41412-780

Fax: +49 40 41412-779

E-mail: info@grand-elysee.com